Abstract: The present disclosure provides processes for isolating target nucleated cells, such as fetal mesenchymal stem cells, from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and methods of using isolated targeted nucleated cells methods and their progeny for detecting fetal abnormalities and stem cell therapy.
Abstract: The present disclosure provides processes for the separation of nucleated cells from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and devices and kits useful in the processes of the disclosure.
Abstract: The present disclosure provides processes for isolating target nucleated cells, such as fetal mesenchymal stem cells, from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and methods of using isolated targeted nucleated cells methods and their progeny for detecting fetal abnormalities and stem cell therapy.
Abstract: The present disclosure provides processes for the separation of nucleated cells from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and devices and kits useful in the processes of the disclosure.